ATE178053T1 - N2s2-chelatoren des hydrazino-typs - Google Patents
N2s2-chelatoren des hydrazino-typsInfo
- Publication number
- ATE178053T1 ATE178053T1 AT94925320T AT94925320T ATE178053T1 AT E178053 T1 ATE178053 T1 AT E178053T1 AT 94925320 T AT94925320 T AT 94925320T AT 94925320 T AT94925320 T AT 94925320T AT E178053 T1 ATE178053 T1 AT E178053T1
- Authority
- AT
- Austria
- Prior art keywords
- hydrazino
- chelators
- type
- targetting molecules
- conjugation
- Prior art date
Links
- 239000002738 chelating agent Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000021615 conjugation Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/534—Production of labelled immunochemicals with radioactive label
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Cell Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Amplifiers (AREA)
- Measurement Of Radiation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11650493A | 1993-09-03 | 1993-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE178053T1 true ATE178053T1 (de) | 1999-04-15 |
Family
ID=22367562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94925320T ATE178053T1 (de) | 1993-09-03 | 1994-08-31 | N2s2-chelatoren des hydrazino-typs |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5574140A (de) |
| EP (1) | EP0716647B1 (de) |
| JP (1) | JP3602848B2 (de) |
| AT (1) | ATE178053T1 (de) |
| AU (1) | AU7528894A (de) |
| CA (1) | CA2169269A1 (de) |
| DE (1) | DE69417426T2 (de) |
| WO (1) | WO1995006633A1 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858327A (en) * | 1993-09-03 | 1999-01-12 | Resolutions Pharmaceuticals, Inc. | Hydrazino-type N2 S2 radionuclide chelating compounds |
| US5804158A (en) * | 1995-05-31 | 1998-09-08 | Resolution Pharmaceuticals Inc. | Sequestered imaging agents |
| DE19536783A1 (de) * | 1995-09-21 | 1997-03-27 | Diagnostikforschung Inst | Bifunktionelle Nicotinamid-Chelatbildner vom Typ N¶2¶S¶2¶ für radioaktive Isotope |
| WO1998033809A1 (en) * | 1997-01-31 | 1998-08-06 | The General Hospital Corporation | Compositions and methods for imaging gene expression |
| AU9307498A (en) * | 1997-09-08 | 1999-03-29 | General Hospital Corporation, The | Imaging agents for early detection and monitoring of cardiovascular plaque |
| US7060251B1 (en) | 1997-09-08 | 2006-06-13 | The General Hospital Corporation | Imaging agents for early detection and monitoring of cardiovascular plaque |
| US6409987B1 (en) | 1999-04-07 | 2002-06-25 | Intimax Corporation | Targeted agents useful for diagnostic and therapeutic applications |
| US6907280B2 (en) * | 1999-12-02 | 2005-06-14 | The General Hospital Corporation | Method and apparatus for objectively measuring pain, pain treatment and other related techniques |
| AU1943301A (en) * | 1999-12-02 | 2001-06-12 | General Hospital Corporation, The | Method and apparatus for measuring indices of brain activity |
| US8623822B2 (en) | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
| US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
| SI2301587T1 (sl) | 2002-03-01 | 2014-11-28 | Dyax Corp. | KDR in VEGF/KDR vezavni peptidi in njihova uporaba pri diagnozi |
| US7794693B2 (en) | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
| WO2004065621A1 (en) | 2002-03-01 | 2004-08-05 | Dyax Corp. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| ES2557286T3 (es) | 2003-03-03 | 2016-01-25 | Dyax Corp. | Usos de péptidos que se unen específicamente al receptor del HGF (cMet) |
| EP2111237B1 (de) | 2006-12-11 | 2015-03-18 | BRACCO IMAGING S.p.A. | Fibrin-bindende peptide und ihre konjugate |
| EP2147684A1 (de) | 2008-07-22 | 2010-01-27 | Bracco Imaging S.p.A | Selektiv gegen Metallproteasen wirkende Diagnosemittel |
| US20150344523A1 (en) | 2014-05-05 | 2015-12-03 | California Institute Of Technology | Mutant akt-specific capture agents, compositions, and methods of using and making |
| IL256833B2 (en) | 2015-07-15 | 2025-07-01 | California Inst Of Techn | IL-17F-specific binding agents, compositions and methods of use and preparation |
| US11370826B2 (en) | 2016-02-09 | 2022-06-28 | Bracco Suisse Sa | Recombinant chimeric protein for selectins targeting |
| WO2017176769A1 (en) | 2016-04-04 | 2017-10-12 | Indi Molecular, Inc. | Cd8-specific capture agents, compositions, and methods of using and making |
| EP3519425B1 (de) | 2016-09-29 | 2024-02-28 | Indi Molecular, Inc. | Zusammensetzungen zum nachweis, zur hemmung und zur bildgebung von indolamin 2,3-dioxygenase 1 (ido1) und verfahren zur herstellung und verwendung davon |
| US11358982B2 (en) | 2016-11-01 | 2022-06-14 | Ohio State Innovation Foundation | Methods for the iodination of biomolecules |
| EP3638687A1 (de) | 2017-06-15 | 2020-04-22 | Indi Molecular, Inc. | Il-17f- und il-17a-spezifische fänger, zusammensetzungen und verfahren zur verwendung und herstellung davon |
| US11638764B2 (en) | 2018-11-08 | 2023-05-02 | Indi Molecular, Inc. | Theranostic capture agents, compositions, and methods of using and making |
| US12216122B2 (en) | 2019-05-20 | 2025-02-04 | Regeneron Pharmaceuticals, Inc. | Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (IDO1) |
| US11414460B2 (en) | 2019-07-19 | 2022-08-16 | Institute For Systems Biology | KRAS-specific capture agents, compositions, and methods of making and using |
| WO2022098743A1 (en) | 2020-11-03 | 2022-05-12 | Indi Molecular, Inc. | Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1) |
| WO2022098745A1 (en) | 2020-11-03 | 2022-05-12 | Indi Molecular, Inc. | Compositions, delivery systems, and methods useful in tumor therapy |
| KR20240040769A (ko) | 2021-07-26 | 2024-03-28 | 아비나스 오퍼레이션스, 인코포레이티드 | 이작용성 화합물을 제조하는 방법 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60184571A (ja) * | 1984-03-01 | 1985-09-20 | Miyoshi Kasei:Kk | 水素添加レシチンにより表面処理した化粧料用顔料 |
| US4980147A (en) * | 1984-06-25 | 1990-12-25 | University Of Utah Research Foundation | Radiolabeled technetium chelates for use in renal function determinations |
| US5175343A (en) * | 1985-01-14 | 1992-12-29 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
| US5037630A (en) * | 1985-01-14 | 1991-08-06 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
| US5120526A (en) * | 1985-01-14 | 1992-06-09 | Neorx Corporation | Method of producing metal radionuclide labeled proteins for diagnosis and therapy |
| US4897255A (en) * | 1985-01-14 | 1990-01-30 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
| JPS63113081A (ja) * | 1985-07-29 | 1988-05-18 | Shiseido Co Ltd | 改質粉体 |
| ATE52516T1 (de) * | 1986-05-28 | 1990-05-15 | Mallinckrodt Inc | Technetiumchelate fuer die bestimmung der nierenfunktion. |
| US5187264A (en) * | 1986-05-28 | 1993-02-16 | Mallinckrodt Medical, Inc. | Technetium chelates to be used for determining the renal function |
| US5082930A (en) * | 1986-05-29 | 1992-01-21 | Mallinckrodt Medical, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
| US4861869A (en) * | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
| US5091514A (en) * | 1987-03-26 | 1992-02-25 | Neorx Corporation | Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy |
| US4965392A (en) * | 1987-03-26 | 1990-10-23 | Neorx Corporation | Chelating compounds for metal-radionuclide labeled proteins |
| IL89222A (en) * | 1988-02-09 | 1995-03-30 | Mallinckrodt Inc | Preparation of metal-radionuclide-labelled proteins, certain novel compounds used therein and radiopharmaceutical compositions containing the labelled proteins |
| US5202451A (en) * | 1988-02-17 | 1993-04-13 | Neorx Corporation | Anchimeric radiometal chelating compounds |
| JPH01224309A (ja) * | 1988-03-03 | 1989-09-07 | Pola Chem Ind Inc | 化粧料 |
| US5089249A (en) * | 1988-06-10 | 1992-02-18 | Neorx Corporation | Conjugates for bone imaging and bone cancer therapy |
| US5196515A (en) * | 1989-03-17 | 1993-03-23 | The Johns Hopkins University | Thiolactone bifunctional chelating agents for diagnostic and therapeutic products |
| JP2801639B2 (ja) * | 1989-05-11 | 1998-09-21 | 株式会社三光生物科学研究所 | メイクアップ用皮膚化粧料組成物 |
| DE3930674A1 (de) * | 1989-09-11 | 1991-03-21 | Diagnostikforschung Inst | Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie |
| US5175257A (en) * | 1989-12-29 | 1992-12-29 | Neorx Corporation | Radiolabeled proteins for diagnostic or therapeutic use |
| US5112953A (en) * | 1989-12-29 | 1992-05-12 | Neorx Corporation | Radiolabeled proteins for diagnostic or therapeutic use |
| JP3005943B2 (ja) * | 1990-04-17 | 2000-02-07 | マリンクロッド・インコーポレイテッド | テクネチウム―99m錯化合物製造のための方法及びキット |
| JP2978989B2 (ja) * | 1990-12-04 | 1999-11-15 | エンジェルハード・コーポレイション | 改良板状顔料 |
| WO1992010214A1 (en) * | 1990-12-12 | 1992-06-25 | Mallinckrodt Medical, Inc. | Method of radioactive labelling of blood cells and kit therefor |
| US5243073A (en) * | 1990-12-14 | 1993-09-07 | Mallinckrodt Medical, Inc. | Hexadentate ligands useful in radiographic imaging agents |
| US5908931A (en) * | 1990-12-14 | 1999-06-01 | Mallinckrodt Inc. | Preorganized hexadentate ligands useful in radiographic imaging agents |
| US5112595A (en) * | 1990-12-21 | 1992-05-12 | Mallinckrodt Medical, Inc. | 99MTC(III) myocardial imaging agents and method of use |
| US5112594A (en) * | 1991-04-04 | 1992-05-12 | Mallinckrodt Medical, Inc. | Kit for preparing a technetium-99m myocardial imaging agent |
| AU1995392A (en) * | 1991-05-08 | 1992-12-21 | Mallinckrodt Medical, Inc. | Technetium chelates to be used for determining the renal function |
| EP0588905A1 (de) * | 1991-06-03 | 1994-03-30 | Mallinckrodt Medical, Inc. | Radioaktiv markierte somatostatinderivate, ihre herstellung und verwendung |
| JPH06510759A (ja) * | 1991-08-05 | 1994-12-01 | マリンクロッド・インコーポレイテッド | 造影剤として使用する重金属クラスター |
-
1994
- 1994-07-14 US US08/274,850 patent/US5574140A/en not_active Expired - Lifetime
- 1994-08-31 EP EP94925320A patent/EP0716647B1/de not_active Expired - Lifetime
- 1994-08-31 DE DE69417426T patent/DE69417426T2/de not_active Expired - Lifetime
- 1994-08-31 AT AT94925320T patent/ATE178053T1/de not_active IP Right Cessation
- 1994-08-31 JP JP50784895A patent/JP3602848B2/ja not_active Expired - Fee Related
- 1994-08-31 CA CA002169269A patent/CA2169269A1/en not_active Abandoned
- 1994-08-31 AU AU75288/94A patent/AU7528894A/en not_active Abandoned
- 1994-08-31 WO PCT/CA1994/000479 patent/WO1995006633A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69417426T2 (de) | 1999-10-28 |
| WO1995006633A1 (en) | 1995-03-09 |
| EP0716647A1 (de) | 1996-06-19 |
| DE69417426D1 (de) | 1999-04-29 |
| AU7528894A (en) | 1995-03-22 |
| JP3602848B2 (ja) | 2004-12-15 |
| EP0716647B1 (de) | 1999-03-24 |
| JPH09503496A (ja) | 1997-04-08 |
| US5574140A (en) | 1996-11-12 |
| CA2169269A1 (en) | 1995-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69417426D1 (de) | N2s2-chelatoren des hydrazino-typs | |
| GR3026658T3 (en) | Hydrazino-type radionuclide chelators having an n 3?s configuration | |
| DE69434384D1 (de) | Metalkomplexbildner | |
| ATE58297T1 (de) | Kupplungsmittel zum radiomarkieren von proteinen. | |
| EA200001169A1 (ru) | Специфично связывающиеся молекулы для сцинтиграфии, содержащие их конъюгаты и терапевтический способ лечения ангиогенеза | |
| NO301829B1 (no) | 2-pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og farmasöytiske preparater basert på disse | |
| ATE194845T1 (de) | Von peptiden abgeleitete komplexbildner für radionuklide | |
| DK0570493T3 (da) | Technetium-99m-mærkede polypeptider til billeddannelse. | |
| NO304552B1 (no) | Kompleksforbindelser, konjugater, farmas°ytiske preparater inneholdende slike og forbindelser | |
| BG105853A (en) | Kit for radiolabeling proteins with yttrium-90 | |
| EP0724456A4 (de) | Antikörper gegen cd40 | |
| FI951138A7 (fi) | Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa | |
| TR199802423T2 (xx) | Konsantre antikor terkibi. | |
| EP0350846A3 (en) | Condensed heterocyclic compounds and their use in therapy | |
| ATE160222T1 (de) | Photoaktivierung von proteinen zu konjugationszwecken | |
| FI943724A0 (fi) | Stabiloidut radiofarmaseuttiset pakkaukset | |
| PT98193A (pt) | Estojo para a dosagem especifica de angiotensina ii | |
| ATE220688T1 (de) | Tumor-zerstörende effekte von enterotoxinen und verwandten verbindungen | |
| DE69230798D1 (de) | Rekombinante immuntoxine | |
| DE69127334D1 (de) | Verabreichung von Mitteln | |
| ATE410514T1 (de) | Calciumbindende rekombinante antikörper gegen protein c | |
| NO953865L (no) | Bifunksjonelle chelatorer og deres anvendelse i radiofarmasöytiske midler | |
| DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
| DK0720597T3 (da) | Triarylethylenderivater til terapeutisk anvendelse | |
| EP0659764A3 (de) | Peptide modifiziert durch eine Phosphin Gruppe zur Markierung mit 99mTC und 186-188Re oder paramagnetische Agentien. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |